QIAGEN’s therascreen PDGFRA RGQ PCR kit approved in U.S. to aid in identifying patients with unresectable or metastatic gastrointestinal stromal tumors positive for the PDGFRA D842V mutation who may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback